| C group | H group | HH group | P-value |
---|---|---|---|---|
Used in real-time PCR and western blot analysis | ||||
Number of patients | 20 | 20 | 20 | Â |
Age (months) | 24.6 ± 8.30 | 21.4 ± 13.4 | 22.4 ± 7.67 | ns |
Body weight (kg) | 12.1 ± 2.48 | 11.1 ± 3.59 | 11.1 ± 1.89 | ns |
Sex (female/male) | 10/10 | 11/9 | 12/8 | ns |
Peak systolic pressure gradient across the pulmonary valve (mmHg)* | 6.5 ± 3.09 | 78.8 ± 40.51 | 86.2 ± 14.75 | <0.001 vs C group |
O 2 (% saturation)* | 98.4 ± 1.15 | 98.3 ± 1.59 | 81.5 ± 5.49 | <0.001 vs HH group |
Used for cell size and IF analysis | ||||
Number of patients | 5 | 5 | 5 | Â |
Age (months) | 17.8 ± 5.97 | 17.4 ± 5.81 | 19.0 ± 5.70 | ns |
Body weight (kg) | 11.0 ± 2.21 | 9.6 ± 1.88 | 11.7 ± 1.17 | ns |
Sex (female/male) | 2/3 | 3/2 | 2/3 | ns |
Peak systolic pressure gradient across the pulmonary valve (mmHg)* | 8.2 ± 3.28 | 61.4 ± 9.94 | 79.2 ± 11.03 | <0.001 vs C group |
O 2 (% saturation)* | 98.5 ± 0.87 | 97.8 ± 1.10 | 82.3 ± 5.94 | <0.01 vs HH group |